(1) Background: The aim of this study was to compare the survival benefit of radical antegrade modular pancreatosplenectomy (RAMPS) with conventional distal pancreatosplenectomy (cDPS) in left-sided pancreatic cancer. (2) Methods: A retrospective propensity score matching (PSM) analysis was conducted on 333 patients who underwent RAMPS or cDPS for left-sided pancreatic cancer at four tertiary cancer centers. The study assessed prognostic factors and compared survival and operative outcomes. (3) Results: After PSM, 99 patients were matched in each group. RAMPS resulted in a higher retrieved lymph node count than cDPS (15.0 vs. 10.0,p< 0.001). No significant differences were observed between the two groups in terms of R0 resection rate, blood loss, hospital stay, or morbidity. The 5-year overall survival rate was similar in both groups (cDPS vs. RAMPS, 44.4% vs. 45.2%,p= 0.853), and disease-free survival was also comparable. Multivariate analysis revealed that ASA score, preoperative CA19-9, histologic differentiation, R1 resection, adjuvant treatment, and lymphovascular invasion were significant prognostic factors for overall survival. Preoperative CA19-9, histologic differentiation, T-stage, adjuvant treatment, and lymphovascular invasion were independent significant prognostic factors for disease-free survival. (4) Conclusions: Although RAMPS resulted in a higher retrieved lymph node count, survival outcomes were not different between the two groups. RAMPS was a surgical option to achieve R0 resection rather than a standard procedure.
(1) 背景:本研究旨在比较根治性顺行模块化胰脾切除术(RAMPS)与传统远端胰脾切除术(cDPS)在左侧胰腺癌治疗中的生存获益差异。(2) 方法:对四家三级癌症中心接受RAMPS或cDPS治疗的333例左侧胰腺癌患者进行回顾性倾向评分匹配分析,评估预后因素并比较生存与手术结局。(3) 结果:经倾向评分匹配后,两组各纳入99例患者。RAMPS组淋巴结清扫数量显著高于cDPS组(15.0枚 vs. 10.0枚,p<0.001)。两组在R0切除率、术中失血量、住院时间及并发症发生率方面均无显著差异。5年总生存率相近(cDPS组 vs. RAMPS组:44.4% vs. 45.2%,p=0.853),无病生存率亦无统计学差异。多因素分析显示:ASA评分、术前CA19-9水平、组织学分化程度、R1切除、辅助治疗及淋巴血管侵犯是总生存的独立预后因素;术前CA19-9水平、组织学分化程度、T分期、辅助治疗及淋巴血管侵犯是无病生存的独立预后因素。(4) 结论:虽然RAMPS能获得更高的淋巴结清扫数量,但两组生存结局无显著差异。RAMPS是实现R0切除的可选术式,而非标准治疗方案。